According to a study published by researchers on Sunday on the medical preprint website medRxiv, the variant of the novel coronavirus found in the UK is related to the high viral load in the blood.
Related to higher viral load
Researchers tested that the highly infectious coronavirus variant in the United Kingdom is related to the high viral load in the blood, according to a study published on Sunday on the medical preprint website medRxiv.
Research director Michael Kidd said in an interview that about 35% of patients infected with mutant viruses have high levels of the virus in blood samples.
The results show that the higher the virus load, the worse the condition will be.
The study has not yet been peer-reviewed.
Kidd said that further research is needed to confirm or refute these findings. If confirmed, he hopes scientists will study how this particular variant replicates the virus in patients.
Early antibody production is the key to recovery.
In another study, researchers at Yale University School of Medicine recently found that the speed, not the number, of antibodies, patients produce antibodies, determine whether they can survive against the novel coronavirus.
Researchers studied more than 200 patients with COVID-19, including 179 hospitalized patients. They found that patients who produced neutralizing antibodies within 14 days of symptoms eventually recovered, while patients who produced neutralizing antibodies after 14 days produced higher viral loads and worsened.
The researchers said: “It is not clear why antibodies produced after this time point do not promote the removal and recovery of patients with COVID-19.
The virus may become resistant by hiding in difficult-to-reach tissues.
The new finding suggests that using monoclonal antibody drugs to treat patients with COVID-19 may only work if they are used immediately after infection.